Toxic encephalopathy and peripheral neuropathy of poisoning by Avermectin Pyridine: a case report and a review of the literature | Canada Hyperbarics Skip to main content
Case Report Front Neurol 2023

Toxic encephalopathy and peripheral neuropathy of poisoning by Avermectin Pyridine: a case report and a review of the literature

Diao J, Zhou Q — Front Neurol, 2023

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported on a 15-year-old girl who suffered severe neurological damage after being poisoned by Avermectin Pyridaben, a highly toxic insecticide.

What They Found

The patient presented with coma, respiratory failure, limb weakness, and ataxia after ingesting the poison. Brain MRI, nerve conduction studies, and electromyography confirmed toxic encephalopathy and peripheral nerve injury. Her limb function gradually recovered over two months with treatment including hyperbaric oxygen therapy, glucocorticoid pulses, and neurotrophic drugs.

What This Means for Canadian Patients

While Avermectin Pyridaben poisoning is rare, this case suggests that hyperbaric oxygen therapy, alongside other medical interventions, could potentially help patients recover from severe neurological damage caused by acute toxic exposures. This information might be valuable for Canadian clinicians managing similar complex poisoning cases.

Canadian Relevance

No direct Canadian connection identified.

Study Limitations

As a single case report, this study's findings cannot be broadly applied to all patients with similar poisoning or used to establish definitive treatment protocols.

Was this summary helpful?

Study Details

Study Type Case Report
Category Neurological
Source Pubmed
PubMed ID 37333003
Year Published 2023
Journal Front Neurol

Cite This Study

Share
Discuss with a qualified healthcare professional. Then: Review Coverage Guide View Recognised Conditions

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.